Seres Therapeutics



Seres Therapeutics is developing revolutionary microbiome-based therapeutics to treat serious diseases.

Barbara Mcgovern
Vice President, Medical Affairs
Carlo Tanzi
Vice President, Investor Relations and Corporate Communications
Gloria G. Cosgrove
Vice President, Quality Systems
Jeff York
Vice President, Human Resources
Jennifer Russo Wortman
Vice President, Clinical Discovery & Research Technologies
Jim Weston
Senior Regulatory Advisor
John Aunins
EVP, Bioprocess & Manufacturing
Kelly M. Brady
Vice President, Clinical Operations
Lisa von Moltke
EVP, Chief Medical Officer
Marcus Chapman
SVP, Principal Financial Officer
Matthew Henn
EVP, Chief Scientific Officer
Terri Young
EVP, Chief Commercial and Strategy Officer
Thomas J. Desrosier
EVP, Chief Legal Officer and Secretary
Viekera Pak
Vice President, Medical Affairs
David Ege
EVP, Chief Technology Officer
Kristin Ainsworth
SVP, Corporate Communications

No teams yet!

No jobs yet!

No wires yet!

By clicking "Continue" or continuing to use our site, you acknowledge that you accept our Privacy Policy and Terms of Use. We also use cookies to provide you with the best possible experience on our website.